Company Overview of Naurex, Inc.
Naurex, Inc. is a biopharmaceutical company that is focused on the discovery, development, and commercialization of medicines for the treatment of psychiatric and neurologic disorders. Its platform discovers compounds that modulate the N-methyl-D-aspartate receptor that is important for normal brain and nervous system function. The company’s products include Rapastinel and NRX-1074 compounds for rapid and substantial reduction in depressive symptoms in subjects with major depressive disorder. Naurex, Inc. was founded in 2006 and is based in Evanston, Illinois. As of August 28, 2015, Naurex, Inc. operates as a subsidiary of Allergan plc.
1801 Maple Avenue
Evanston, IL 60201
Founded in 2006
Key Executives for Naurex, Inc.
Naurex, Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
To contact Naurex, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.